ETF of the Moment: A Budding Comeback for Cannabis

The cannabis ETF MSOS has surged 44% in a single month, making it the 'ETF of the Moment' on Bloomberg's Trillions podcast — not because it's a new winner, but because it's a long-suffering underdog finally getting a lifeline. The catalyst? The U.S. Department of Justice's rescheduling of marijuana from Schedule I to Schedule III, a move that, while not legalization, unlocks critical tax benefits for medical cannabis operations. This shift allows companies to deduct operating expenses — a game-changer that could dramatically improve profitability. MSOS stands out among cannabis ETFs not just for its recent rally, but because it's the only one with over $1 billion in assets, offering direct exposure to U.S. multi-state operators via swaps — a legal workaround since cannabis remains federally illegal. Despite this, the ETF is still down 88% from its peak, underscoring how deeply beaten down the sector has been. The podcast warns this is a high-risk, high-reward play, best suited for a small allocation in a 'hot sauce' portfolio. Yet the momentum suggests a broader shift: after years of regulatory paralysis, the industry may finally be emerging from the shadows — not with a bang, but with a cautious, tax-driven sigh of relief.